Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02638766
Title Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST (REGISTRI)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Grupo Espanol de Investigacion en Sarcomas
Indications

gastrointestinal stromal tumor

Therapies

Regorafenib

Age Groups: adult | senior
Covered Countries

Additional content available in CKB BOOST